ebook Munafa Stock Market Course + Intraday & FNO calls  

       

DRREDDY announcements Dr. Reddy's Laboratories Limited announcements and dividends declared NSE

Dr. Reddy's Laboratories Limited Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Limited DRREDDY

Dr. Reddy's Laboratories Limited DRREDDY listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Limited DRREDDY

Gainers & Losers: IIFL Finance, Dr Reddy’s among 7 stocks that moved most on Thursday
Indian markets snapped a three-day losing streak as Nifty and Sensex closed higher. Stocks like Gokaldas Exports, CreditAccess Grameen and Amagi gained, while IIFL Finance and PNB Housing fell sharply despite earnings updates.
Announcement as on 22 January 2026

Dr Reddy's Laboratories Q3 Results: Profit falls 14% YoY to Rs 1,210 crore, revenue up 4%
Dr Reddy’s Laboratories reported a 14% YoY drop in Q3 net profit to Rs 1,210 crore, even as revenue rose 4% to Rs 8,727 crore. Lower margins and a 12% decline in North America sales weighed on performance, partly offset by strong growth in India, Europe an
Announcement as on 21 January 2026

Dr Reddy's Q3 preview: PAT may fall 22% YoY as US pressure to weigh on earnings
Dr Reddy's Laboratories anticipates a subdued performance for the December quarter. Pressure from its United States business is expected to offset steady growth in India and Europe. Analysts predict a decline in revenue and profit after tax. The US market
Announcement as on 20 January 2026

Company Announcement
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 14, 2026, titled "Dr. Reddy s announces the first-to-market launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the generic equivalent o
Announcement as on 16 January 2026

Company Announcement
Dr. Reddy's Laboratories Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Announcement as on 12 January 2026

Announcements by Dr. Reddy's Laboratories Limited first page | Next page | Prev page |

DRREDDY Dr. Reddy's Laboratories Limited current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Limited

  • 5Day Average: 1308.6
  • 12Day Average: 1288.25
  • 20Day Average: 1284
  • 50Day Average: 1290.67
  • 100Day Average: 1277.78
  • 150Day Average: 1267.06
  • 200Day Average: 1265.09

DRREDDY Indicators & signals

Indicator MACD (12,26,9)

1298.53, 1292.42, -1.34
Indicator MACD is in positive zone

Indicator ADX (14)

39.71, 29.06, 12.54
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 65
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of DRREDDY Dr. Reddy's Laboratories Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
25 Thu Jun 2026 1350.50 1331.90 to 1363.00 1.66% 1.14 times
24 Wed Jun 2026 1328.40 1306.20 to 1343.00 2.08% 2.24 times
23 Tue Jun 2026 1301.30 1294.90 to 1329.50 0.82% 1.93 times
22 Mon Jun 2026 1290.70 1271.20 to 1306.00 1.46% 1.08 times
19 Fri Jun 2026 1272.10 1261.00 to 1275.00 0.36% 0.88 times
18 Thu Jun 2026 1267.50 1261.70 to 1279.90 -0.12% 0.52 times
17 Wed Jun 2026 1269.00 1260.90 to 1277.40 -0.62% 0.46 times
16 Tue Jun 2026 1276.90 1269.10 to 1286.00 -0.2% 0.29 times
15 Mon Jun 2026 1279.50 1275.30 to 1296.20 0.32% 0.79 times
12 Fri Jun 2026 1275.40 1266.00 to 1291.00 -0.05% 1.1 times
11 Thu Jun 2026 1276.00 1266.40 to 1285.70 0.34% 0.71 times
10 Wed Jun 2026 1271.70 1266.70 to 1283.70 0.25% 0.79 times

Videos related to: DRREDDY announcements Dr. Reddy's Laboratories Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

DRREDDY announcements Dr. Reddy's Laboratories Limited announcements and dividends declared NSE

 

Back to top